NasdaqGS - Nasdaq Real Time Price USD

Nkarta, Inc. (NKTX)

1.7400
+0.0200
+(1.16%)
At close: May 16 at 4:00:00 PM EDT
1.7199
-0.02
(-1.16%)
After hours: May 16 at 4:31:45 PM EDT
Advanced Chart
Loading Chart for NKTX
  • Previous Close 1.7200
  • Open 1.7400
  • Bid 1.2500 x 200
  • Ask 2.2000 x 200
  • Day's Range 1.7000 - 1.7550
  • 52 Week Range 1.3100 - 8.2300
  • Volume 589,704
  • Avg. Volume 1,361,233
  • Market Cap (intraday) 123.466M
  • Beta (5Y Monthly) 0.81
  • PE Ratio (TTM) --
  • EPS (TTM) -1.6200
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 13.20

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

www.nkartatx.com

109

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Nkarta, Inc.

Recent News: NKTX

View More
View More

Performance Overview: NKTX

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NKTX
30.12%
S&P 500 (^GSPC)
1.30%

1-Year Return

NKTX
74.49%
S&P 500 (^GSPC)
12.48%

3-Year Return

NKTX
87.45%
S&P 500 (^GSPC)
48.66%

5-Year Return

NKTX
96.80%
S&P 500 (^GSPC)
108.07%

Compare To: NKTX

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

NKTX
Nkarta, Inc.
1.7400
+1.16%
Mkt Cap 123.466M
Industry Biotechnology
IPSC
Century Therapeutics, Inc.
0.5600
+8.23%
Mkt Cap 48.249M
Industry Biotechnology
HLVX
HilleVax, Inc.
1.9700
+0.51%
Mkt Cap 98.698M
Industry Biotechnology
IKNA
Ikena Oncology, Inc.
1.1100
+0.91%
Mkt Cap 53.566M
Industry Biotechnology
RPTX
Repare Therapeutics Inc.
1.3400
+0.75%
Mkt Cap 57.474M
Industry Biotechnology
CRGX
CARGO Therapeutics, Inc.
4.1200
+3.26%
Mkt Cap 189.987M
Industry Biotechnology
FATE
Fate Therapeutics, Inc.
1.0700
+5.94%
Mkt Cap 122.657M
Industry Biotechnology
KZR
Kezar Life Sciences, Inc.
4.0700
+0.25%
Mkt Cap 29.735M
Industry Biotechnology
OKUR
OnKure Therapeutics, Inc.
2.0000
-2.91%
Mkt Cap 27.021M
Industry Biotechnology
PMVP
PMV Pharmaceuticals, Inc.
0.8659
+3.32%
Mkt Cap 44.986M
Industry Biotechnology
ITOS
iTeos Therapeutics, Inc.
7.81
-2.01%
Mkt Cap 298.918M
Industry Biotechnology

Statistics: NKTX

View More

Valuation Measures

Annual
As of 5/15/2025

  • Market Cap

    122.05M

  • Enterprise Value

    -65.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.30

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -15.14%

  • Return on Equity (ttm)

    -26.10%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -111.25M

  • Diluted EPS (ttm)

    -1.6200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    265.51M

  • Total Debt/Equity (mrq)

    20.83%

  • Levered Free Cash Flow (ttm)

    -63.63M

View More

Research Analysis: NKTX

View More
View More

Company Insights: NKTX

Research Reports: NKTX

View More
View More

People Also Watch

ALXO ALX Oncology Holdings Inc.
0.4374
+0.37%
 
PLRX Pliant Therapeutics, Inc.
1.3800
+0.73%
 
STOK Stoke Therapeutics, Inc.
9.76
+1.35%
 
BDTX Black Diamond Therapeutics, Inc.
1.9500
+1.04%
 
FDMT 4D Molecular Therapeutics, Inc.
3.4400
+7.50%
 
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
 
CCCC C4 Therapeutics, Inc.
1.3800
0.00%
 
ORIC ORIC Pharmaceuticals, Inc.
4.7300
-0.21%
 
NRIX Nurix Therapeutics, Inc.
9.56
+1.06%
 
GBIO Generation Bio Co.
0.3813
+1.52%
 
PASG Passage Bio, Inc.
0.3020
+1.55%
 
RVMD Revolution Medicines, Inc.
39.54
+0.25%
 
PMVP PMV Pharmaceuticals, Inc.
0.8659
+3.32%
 
ANNX Annexon, Inc.
2.0100
+11.05%
 
SANA Sana Biotechnology, Inc.
1.7450
+2.05%
 
RNA Avidity Biosciences, Inc.
30.35
+4.76%